Literature DB >> 11731329

Cellular cholesterol efflux.

C J Fielding1, P E Fielding.   

Abstract

Efflux of free cholesterol (FC) continues even when cellular FC mass is unchanged. This reflects a recirculation of preformed FC between cells and extracellular fluids which has multiple functions in cell biology including receptor recycling and signaling as well as cellular FC homeostasis. Total FC efflux is heterogeneous. Simple diffusion to mature high density lipoprotein (HDL), mainly via albumin as intermediate, initiates FC net transport driven by plasma lecithin:cholesterol acyltransferase activity. A second major efflux component reflects protein-facilitated transport from cell surface domains (caveolae, rafts) driven by FC binding to lipid-poor, pre-beta-migrating HDL (pre-beta-HDL). Facilitated efflux from caveolae, unlike simple diffusion, is highly regulated. Neither ABC1 (the protein defective in Tangier disease) nor other ATP-dependent transporters now appear likely to contribute directly to FC efflux. Their role is limited to the initial formation of a particle precursor to circulating pre-beta-HDL, which recycles without further lipid input from ATP-dependent transporter proteins. Lipid-free apolipoprotein A-I, previously considered a surrogate for pre-beta-HDL, has a reactivity much lower than that of native lipoprotein FC acceptors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731329     DOI: 10.1016/s1388-1981(01)00162-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  34 in total

Review 1.  Regulation and mechanisms of macrophage cholesterol efflux.

Authors:  Alan R Tall; Philippe Costet; Nan Wang
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 2.  Intracellular cholesterol transport.

Authors:  Frederick R Maxfield; Daniel Wüstner
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 3.  The role of cholesterol efflux in regulating the fertilization potential of mammalian spermatozoa.

Authors:  Alexander J Travis; Gregory S Kopf
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

4.  Lipoproteins: When size really matters.

Authors:  J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  Curr Opin Colloid Interface Sci       Date:  2006-06       Impact factor: 6.448

5.  Multiple mechanisms limit the accumulation of unesterified cholesterol in the small intestine of mice deficient in both ACAT2 and ABCA1.

Authors:  Stephen D Turley; Mark A Valasek; Joyce J Repa; John M Dietschy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-08-19       Impact factor: 4.052

Review 6.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

7.  Role of the hydrophobic and charged residues in the 218-226 region of apoA-I in the biogenesis of HDL.

Authors:  Panagiotis Fotakis; Andreas K Kateifides; Christina Gkolfinopoulou; Dimitra Georgiadou; Melissa Beck; Katharina Gründler; Angeliki Chroni; Efstratios Stratikos; Dimitris Kardassis; Vassilis I Zannis
Journal:  J Lipid Res       Date:  2013-08-29       Impact factor: 5.922

Review 8.  Causes of dysregulation of lipid metabolism in chronic renal failure.

Authors:  Nosratola D Vaziri
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

Review 9.  The macrophage: the intersection between HIV infection and atherosclerosis.

Authors:  Suzanne M Crowe; Clare L V Westhorpe; Nigora Mukhamedova; Anthony Jaworowski; Dmitri Sviridov; Michael Bukrinsky
Journal:  J Leukoc Biol       Date:  2009-12-01       Impact factor: 4.962

Review 10.  High-density lipoprotein affects antigen presentation by interfering with lipid raft: a promising anti-atherogenic strategy.

Authors:  S-H Wang; S-G Yuan; D-Q Peng; S-P Zhao
Journal:  Clin Exp Immunol       Date:  2010-01-06       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.